Form 4: Merit Medical Director Receives RSU Grant
Statement of Changes in Beneficial Ownership
Director Lynne N. Ward was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
Summary
- Director Lynne N. Ward received a grant of 3,457 restricted stock units (RSUs) on May 18, 2026.
- The RSUs are subject to a vesting schedule with a maturity date of May 3, 2027.
- Vesting is contingent upon the director's continued service to the company through the vesting date.
- Following this transaction, the director's total beneficial ownership of common stock increased to 11,266 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
- Increase in total beneficial ownership by a member of the board.
Negatives
- None identified; this is a standard equity compensation disclosure.
Risks
- Vesting is subject to continued service, creating a dependency on the director's ongoing tenure.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on director equity compensation.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the medical device sector to ensure board members maintain a vested interest in company performance.
Comparison to Industry Standards
- The use of RSU grants for director compensation is consistent with standard practices among mid-cap medical technology companies.
- The vesting period of approximately one year is typical for annual director equity refresh cycles.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Execution of a new Power of Attorney for SEC filing purposes. | 2025-10-03 | Administrative update to facilitate regulatory compliance. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation practices.
Next Steps
- Vesting of the 3,457 RSUs on May 3, 2027, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 2025-10-03 | Date of Power of Attorney execution. |
| 2026-05-18 | Date of RSU grant transaction. |
| 2027-05-03 | Vesting date for the granted RSUs. |
Keywords
Merit Medical Systems, MMSI, Form 4, Director Compensation, Restricted Stock Units, Insider Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.